US Patent 10888613 Method of producing cells resistant to HIV infection
Patent 10888613 was granted and assigned to American Gene Technologies on January, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+228 characters)
Article
Patent abstract
The present invention relates generally to immunotherapy for preventing HIV infection in HIV-negative individuals. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Charles David Pauza0
Haishan Li0
Tyler Lahusen0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 5 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 4 Apr, 2023
Golden AI
Infobox
Edits on 26 Mar, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Golden AI
Infobox
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+15 properties)
US Patent 10888613 Method of producing cells resistant to HIV infection
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10888613
Date of patent
January 12, 2021
Patent application number
16076655
Date Filed
January 11, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 10888613 Method of producing cells resistant to HIV infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
